---
created: 2025-04-13
updated: 2025-04-13T10:53
id: OI;Rk:2`H<
specialty: pharmaco
specialty_id: 493
tags:
  - source/ak-original-decks::step-1::lolnotacop::drugs
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::04-cancer-drugs::06-other-cancer-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::bevacizumab
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::19-bevacizumab
  - "source/ak-step1-v11:": 
  - theme/ome::06-inflammation-neoplasia::08-cycle-chemo
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::11-oncology::bevacizumab
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::03-kinase-inhibitors-&-monoclonal-antibodies::02-rituximab,-cetuximab,-bevacizumab,-alemtuzumab,-trastuzumab
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::7000-7999::7721
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::19000-19999::19198"
type: flashcard
---

# Question
Bevacizumab & ranibizumab are antitumor monoclonal antibodies that target **VEGF** to treat (along with smoking cessation) wet AMD age-related macular degeneration, the leading cause of blindness in industrialized countries

---

# Answer
BeVacizumab inhibits Blood Vessel formation   wet AMD = acute vision loss (days to weeks) with metamorphopsia (distortion of straight lines).  Funduscopy: grayish-green subretinal discoloration with adjacent fluid/hemorrhage     DDX = Dry AMD = gradual vision loss in one or both eyes and can cause difficulty with driving/reading.  calcified drusen (below) x drusen (bottom)